Brickell is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated therapeutics for the treatment of skin diseases.

OUR RESEARCH

Pipeline
Our current pipeline consists of new molecular entities with relevant mechanisms of action in skin diseases, targeting significant market opportunities in the global dermatology market.

 

VIEW PIPELINE
Hyperhidrosis
Hyperhidrosis is a life-altering condition of sweating beyond what is physiologically required to maintain normal thermal regulation and is estimated to affect 15.3 million, or 4.8%, of the U.S. population.

 

LEARN MORE
Brickell Outward Bound Leadership Retreat 2018